Education
About Us
Working with TipRanks
Follow Us
Bioqual Inc (BIOQ)
OTHER OTC:BIOQ
BIOQ Stock Chart & Stats
$38.75
-$1.10(-1.66%)
At close: 4:00 PM EST
$38.75
-$1.10(-1.66%)
Day’s Range― - ―
52-Week Range$33.00 - $66.00
Previous CloseN/A
Volume200.00
Average Volume (3M)223.00
Market Cap
$34.64M
Enterprise Value$38.23M
Total Cash (Recent Filing)$17.85M
Total Debt (Recent Filing)$16.54M
Price to Earnings (P/E)―
Beta-0.12
Next Earnings
Jan 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.28
Shares Outstanding893,838
10 Day Avg. Volume0
30 Day Avg. Volume223
Financial Highlights & Ratios
PEG Ratio0.12
Price to Book (P/B)1.11
Price to Sales (P/S)0.82
P/FCF Ratio14.87
Enterprise Value/Market Cap1.10
Enterprise Value/Revenue0.78
Enterprise Value/Gross Profit-20.16
Enterprise Value/Ebitda21.51
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bioqual News
BIOQ FAQ
What was Bioqual Inc’s price range in the past 12 months?
Bioqual Inc lowest stock price was $33.00 and its highest was $66.00 in the past 12 months.
What is Bioqual Inc’s market cap?
Bioqual Inc’s market cap is $34.64M.
When is Bioqual Inc’s upcoming earnings report date?
Bioqual Inc’s upcoming earnings report date is Jan 27, 2026 which is in 12 days.
How were Bioqual Inc’s earnings last quarter?
Bioqual Inc released its earnings results on Oct 21, 2025. The company reported -$0.28 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.28.
Is Bioqual Inc overvalued?
According to Wall Street analysts Bioqual Inc’s price is currently Overvalued.
Does Bioqual Inc pay dividends?
Bioqual Inc pays a Annually dividend of $0.5 which represents an annual dividend yield of N/A. See more information on Bioqual Inc dividends here
What is Bioqual Inc’s EPS estimate?
Bioqual Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bioqual Inc have?
Bioqual Inc has 893,838 shares outstanding.
What happened to Bioqual Inc’s price movement after its last earnings report?
Bioqual Inc reported an EPS of -$0.28 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Bioqual Inc?
Currently, no hedge funds are holding shares in BIOQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bioqual Inc
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.
Technical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
0.29% Other Institutional Investors
99.71% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---